Navigation Links
New research tools for BRAMS via Sonomax Technologies
Date:4/13/2010

This release is available in French.

Montreal, April 13, 2010 - Sonomax Technologies Inc. has been selected by Montral's International Laboratory for Brain, Music and Sound Research (BRAMS) to provide miniaturized, real-time, in-ear, digital signal processing devices (DSP) to investigate experience-dependent brain plasticity in humans.

"Sonomax's digital earplugs allow us to change a person's sound perception, in real time, and to simulate different hearing problems, in and outside of the laboratory," says Dr. Marc Schnwiesner, a Universit de Montral psychology professor, principal investigator with BRAMS and a specialist in high-resolution brain imaging of the hearing system.

BRAMS is jointly affiliated with the Universit de Montral and McGill University's Montral Neurological Institute. Its research is supported by the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council.

Various time and frequency manipulations are performed on the signal pick-up by the microphone and transmitted to the subject's ear by the receiver, while monitoring changes in brain function and perception with neuroimaging techniques and behavioral tests.

"Sonomax's technology enables us to conduct tests in a real-world environment, because the devices are wearable, thus giving us experimental control outside of the laboratory," adds Dr. Schnwiesner.

The technology, along with Dr. Schnwiesner's research, allows the team to modify a participant's sound perception over several weeks, for instance by filtering out certain frequencies and change the directions of incoming sounds.

Although the five-year study is in the preliminary stage and its applications in future technology still premature, Dr. Schnwiesner hopes results will lead to new insights into human sound perception and brain plasticity, as well as improved signal processing methods to enhance a listener's auditory experience.

"The application of Sonomax's in-ear technology demonstrates the versatility of the platform," says Nick Laperle, President & CEO Sonomax Technologies Inc. The sale to BRAMS was valued at $125,000 for Sonomax.

"By providing our products to a world-class research institution such as BRAMS, we can only benefit from some of the results that Dr. Schnwiesner will produce in the future as we continue to develop and enhance our leading edge in-ear products," Mr. Laperle says.


'/>"/>

Contact: Nick Laperle
nlaperle@sonomax.com
514-889-7674
University of Montreal
Source:Eurekalert

Related medicine news :

1. New research identifies modifiable risk factors for heart disease
2. Nuvo Research announces early redemption of 5% convertible debentures
3. Researcher to track spread of disease, malware and power outages
4. UCSF Researchers Identify Regulator of Human Sperm Cells
5. Octapharma Accepting Applications for Research Grants Through March 31
6. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
7. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
8. University of Maryland chemist receives Astellas Award for blindness prevention research
9. Developing a cyberinfrastructure for comparative effectiveness in cancer research
10. Women should be allowed to eat, drink during labor: Queens University researcher
11. Parkinsons disease research uncovers social barrier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... Usually, the impending ... daily wardrobe. However, for those self-conscious about a double chin, this means more anxiety ... ideal solution. , “For most people, a double chin is undesirable,” Dr. Goldman ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm ... its corporate headquarters to a new, more expansive office space in order to ... Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 Silas ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... 28, 2017 , ... AutismOne announced the Board Certified in ... Medicine and available for application on Saturday, May 27, 2017, following Thursday, Friday, ... Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities termed ...
(Date:3/28/2017)... , ... March 28, 2017 , ... With expansion and ... Georgia, in early March. , The seed processing plant opened in Marshallville in 2006, ... 2016. The new office allows opportunity for transition of Patten Seed operations to the ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CAMBRIDGE , United Kingdom and  BOSTON ... text analytics provider Linguamatics today announced ... Dow Jones . The agreement allows pharmaceutical companies ... utilizing Linguamatics I2E text mining technology. ... used by 18 of the top 20 global ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology: